AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2022. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,619 | -36.1% | 19,478 | +2.3% | 0.00% | – |
| Q2 2023 | $313,773 | +85.6% | 19,040 | +3.2% | 0.00% | – |
| Q1 2023 | $169,061 | +34.1% | 18,456 | +4.8% | 0.00% | – |
| Q4 2022 | $126,068 | +48.3% | 17,607 | +3.2% | 0.00% | – |
| Q3 2022 | $85,000 | +117.9% | 17,064 | +8.1% | 0.00% | – |
| Q2 2022 | $39,000 | -58.5% | 15,787 | +15.2% | 0.00% | – |
| Q1 2022 | $94,000 | +2.2% | 13,704 | +20.7% | 0.00% | – |
| Q4 2021 | $92,000 | -35.2% | 11,351 | -27.7% | 0.00% | – |
| Q1 2021 | $142,000 | +35.2% | 15,700 | 0.0% | 0.00% | – |
| Q4 2020 | $105,000 | +262.1% | 15,700 | +423.3% | 0.00% | – |
| Q1 2017 | $29,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,625,000 | $12,269,000 | 3.04% |
| GENDELL JEFFREY L | 1,146,764 | $8,658,000 | 1.11% |
| Broadfin Capital, LLC | 1,029,012 | $7,769,000 | 1.04% |
| RTW INVESTMENTS, LP | 3,401,434 | $25,681,000 | 0.97% |
| BRANDES INVESTMENT PARTNERS, LP | 3,651,948 | $27,571,000 | 0.66% |
| Aristides Capital LLC | 71,520 | $540,000 | 0.42% |
| Tekla Capital Management LLC | 814,588 | $6,150,000 | 0.23% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 36,100 | $273,000 | 0.17% |
| Leap Investments LP | 43,481 | $328,000 | 0.15% |
| Brown Capital Management | 1,829,886 | $13,816,000 | 0.13% |